Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression
Open Access
- 27 February 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (5) , 1622
Abstract
The retinoid acid-related orphan receptor α (RORα), a member of the orphan nuclear receptor superfamily, functions as an unknown ligand-dependent transcription factor. RORα was shown to regulate a broad array of physiological processes such as Purkinje cell development in the cerebellum, circadian rhythm, lipid and bone metabolism, inhibition of inflammation, and anti-apoptosis. The human RORα gene encodes at least four distinct isoforms (RORα1, -2, -3, -4), which differ only in their N-terminal domain (NTD). Two isoforms, RORα2 and 3, are not expressed in mice, whereas RORα1 and 4 are expressed both in mice and humans. In the present study, we identified the specific NTD of RORα2 that enhances prostate tumor progression and proliferation via lysine methylation-mediated recruitment of coactivator complex pontin/Tip60. Upregulation of the RORα2 isoform in prostate cancers putatively promotes tumor formation and progression. Furthermore, binding between coactivator complex and RORα2 is increased by lysine methylation of RORα2 because methylation permits subsequent interaction with binding partners. This methylation-dependent activation is performed by SET domain containing 7 (SETD7) methyltransferase, inducing the oncogenic potential of RORα2. Thus, post-translational lysine methylation of RORα2 modulates oncogenic function of RORα2 in prostate cancer. Exploration of the post-translational modifications of RORα2 provides new avenues for the development of tumor-suppressive therapeutic agents through modulating the human isoform-specific tumorigenic role of RORα2.Keywords
Funding Information
- Kangwon National University (2019 Research Grant)
- Korea University (Korea University Medical Center Grant)
- National Research Foundation (NRF) (NRF- 2018R1D1A1A02085592)
This publication has 51 references indexed in Scilit:
- RORα is crucial for attenuated inflammatory response to maintain intestinal homeostasisProceedings of the National Academy of Sciences, 2019
- RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional networkNature Communications, 2017
- Nonhistone Lysine Methylation in the Regulation of Cancer PathwaysCold Spring Harbor Perspectives in Medicine, 2016
- Lysine methylation represses p53 activity in teratocarcinoma cancer cellsProceedings of the National Academy of Sciences, 2016
- Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersClinical Cancer Research, 2016
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate CancerCancer Research, 2013
- DNA Damage-Induced RORα Is Crucial for p53 Stabilization and Increased ApoptosisMolecular Cell, 2011
- G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53Journal of Biological Chemistry, 2010
- RORα1 and RORα4 suppress TNF-α-induced VCAM-1 and ICAM-1 expression in human endothelial cellsFEBS Letters, 2003
- The Co-repressor Hairless Protects RORα Orphan Nuclear Receptor from Proteasome-mediated DegradationJournal of Biological Chemistry, 2003